✦ LIBER ✦

Weight-Related Effects on Disease Progression in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial

✍ Scribed by James E. Everhart; Anna S. Lok; Hae–Young Kim; Timothy R. Morgan; Karen L. Lindsay; Raymond T. Chung; Herbert L. Bonkovsky; Marc G. Ghany

Book ID: 119760986
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 469 KB
Volume: 137
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2009.05.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Silymarin use and liver disease progress

Silymarin use and liver disease progression in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial

✍ N. D. Freedman; T. M. Curto; C. Morishima; L. B. Seeff; Z. D. Goodman; E. C. Wri 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB

Hepatic Steatosis in Hepatitis C: Compar

Hepatic Steatosis in Hepatitis C: Comparison of Diabetic and Nondiabetic Patients in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial

✍ Lok, Anna S.F.; Everhart, James E.; Chung, Raymond T.; Padmanabhan, Latha; Green 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 222 KB

HCV RNA detection by TMA during the hepa

HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial

✍ Chihiro Morishima; Timothy R. Morgan; James E. Everhart; Elizabeth C. Wright; Mi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views

For making treatment decisions related to chronic hepatitis C, the utility of HCV RNA tests with increased sensitivity has not been defined. Prior interferon nonresponders with advanced fibrosis (n ‫؍‬ 1,145) were retreated with peginterferon alpha-2a and ribavirin. Patients who were HCV RNA-negativ

Dietary Cholesterol Intake Is Associated

Dietary Cholesterol Intake Is Associated With Progression of Liver Disease in Patients With Chronic Hepatitis C: Analysis of the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial

✍ Yu, Lei; Morishima, Chihiro; Ioannou, George N. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 272 KB

Herbal product use by persons enrolled i

Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial

✍ Leonard B. Seeff; Teresa M. Curto; Gyongyi Szabo; Gregory T. Everson; Herbert L. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 239 KB 👁 2 views

Herbal products, used for centuries in Far Eastern countries, are gaining popularity in western countries. Surveys indicate that persons with chronic hepatitis C (CHC) often use herbals, especially silymarin (milk thistle extract), hoping to improve the modest response to antiviral therapy and reduc

Evolution of hepatic steatosis in patien

Evolution of hepatic steatosis in patients with advanced hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial

✍ Anna S. Lok; James E. Everhart; Raymond T. Chung; Hae-Young Kim; Gregory T. Ever 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 404 KB 👁 2 views

Hepatic steatosis is a common histologic feature in patients with chronic hepatitis C (CHC) but there are no large longitudinal studies describing the progression of steatosis in CHC. We examined changes in steatosis on serial biopsies among CHC patients participating in the Hepatitis C Antiviral Lo